Curriculum Vitae
Ross John Baldessarini
Born: September 30, 1937, North Adams, MA 01247
Office: Mailman Research Center 312, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106
Tel (617)-855-3203; Fax (617)-855-3479; e-mail: rjb@mrc309.mclean.org
Home: 49 Nehoiden Road, Waban, MA 02168 59 River Road, East Orleans, MA 02643
Tel. (617) 969-1831 (PO Box 939); Tel (508) 255-7713
Wife: Frances Holland 0'Brien Baldessarini, A.B., R.N., M.A.
Children: Anne Ross (b. 5-7-71)
John William (b. 8-21-72)
Education
1959 A.B. (Chemistry, highest honors), magna cum laude Williams College, Williamstown, MA
1963 M.D. (Neuroscience) Johns Hopkins University School of Medicine, Baltimore, MD
1978 M.A. (Honorary) Harvard University, Cambridge, MA
1995 DSc (Honorary) Massachusetts College of Liberal Arts
Postgraduate Training
1963–1964 Internship, Internal Medicine III Medical Service, Boston City Hospital, Boston, MA
1964–1966 Postdoctoral Research Fellow, Laboratory of Clinical Science (NIMH), National Institutes of Health, Bethesda, MD
1966–1969 Fellow and Resident, Department of Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
1967–1968 Resident Clinical Chief, Private Psychiatric Inpatient Service (Henry Phipps Psychiatric Clinic),
Johns Hopkins Hospital, Baltimore, MD
1968–1969 Chief Resident Psychiatrist (Henry Phipps Psychiatric Clinic), Johns Hopkins Hospital, Baltimore, MD
1969 Fellow, Neurosciences Research Program of Mass. Institute of Technology, Intensive Study
Program, Boulder, Colorado
MilitaryService
1964-1966 U.S. Public Health Service (Lt. Commander, retirement grade: Commander)
1966-1980 U.S. Public Health Service (Reserve)
MedicalLicensure
1965– Massachusetts (No. 29098; active)
1965–94 Maryland (No. D00320; inactive)
1965–90 California (Inactive)
2006– National Provider Identifier (NPI) no.:1487644787
Specialty BoardCertification
1972 American Board of Psychiatry & Neurology (No. 11769, January)
Certification in Clinical Research Ethics
2000– Partners HealthCare Inc, Boston, MA
Controlled Substances Permits
1977– Massachusetts (MB-015168)
1977– Federal US-DEA (clinical: AB-5925839; research: PB-0042212, through 1993)
Academic Appointments
1969–1972 Assistant Professor of Psychiatry, Harvard Medical School, Boston, MA
1972–1977 Associate Professor of Psychiatry, Harvard Medical School, Boston, MA
1978– Professor of Psychiatry (tenured), Harvard Medical School, Boston, MA
1983– Professor of Neuroscience in Psychiatry, Harvard Medical School
Institutional Appointments
1966–1969 Lecturer in Physiology Johns Hopkins School of Medicine. Baltimore, MD
1969 Guest Scientist, Neuropsychopharmacology Lab., Massachusetts Mental Health Center, Boston
1969–1973 Assistant Psychiatrist, Mass. General Hospital, Boston, MA
1969–1977 Chief, Laboratory of Neuropsychopharmacology, Mass. General Hospital, Boston, MA
1970– Founding Consulting Psychiatrist, Psychopharmacology Clinic, Massachusetts General Hospital
1972 Acting Co-director, Inpatient Psychiatric Service, Massachusetts General Hospital
1973–1975 Associate Psychiatrist, Massachusetts General Hospital, Boston, MA
1975– Psychiatrist, Massachusetts General Hospital, Boston, Massachusetts
1975– Psychiatrist, McLean Hospital, Belmont, MA
1977– Associate Director, Mailman Labs. for Psychiatric Research, McLean Hospital, Belmont, MA
1978–1979 Acting Director, Mailman Laboratories for Psychiatric Research, McLean Hospital
1983–1988 Interim Director, Laboratories for Psychiatric Research, Mailman Research Center
1988– Director, Laboratories for Psychiatric Research, Mailman Research Center
1988–2004 Founding Director, Bipolar & Psychotic Disorders Program, McLean Hospital
1989– Co-Director, Psychopharmacology Training Service, McLean Hospital
1994– Founding Director, International Consortium on Bipolar Disorder Research, McLean Hospital
1995–2003 Director,Grand Rounds program, McLean Hospital
1996– Senior Consulting Psychiatrist, McLean Hospital & Partners Health Care System
1995–2003 Director, Grand Rounds program, McLean Hospital
1996– Senior Consulting Psychiatrist, McLean Hospital & Partners Health Care System
1996– Director, Psychopharmacology Consultation Service, McLean Hospital
1996– Senior Consulting Psychiatrist, Psychopharmacology Outpatient Clinic, McLean Hospital
1996–2003 Director, Psychopharmacology Training McLean & Massachusetts General Hospitals
2004– Senior Consulting Psychiatrist, Schizophrenia & Bipolar Disorder Program, McLean Hospital
Other Professional Appointments
1965–1966 Lecturer in Neurophysiology, Postgraduate Program, National Institutes of Health, Bethesda, MD
1969–1977 Acting Chief, Psychiatric Research Laboratories, Massachusetts General Hospital (summers)
1970–1975 National Institute of Mental Health Research Career Development Awardee
1975–2001 National Institute of Mental Health Career Scientist Awardee
1976–1977 Acting Deputy Chairman, Department of Psychiatry, Massachusetts General Hospital (summers)
1977– Fellow, American Psychiatric Association (FAPA)
1978 Robins Visiting Professor of Psychiatry, Washington University, St. Louis, MO
1979 Compton Visiting Professor of Chemistry, Williams College, Williamstown, MA
1979 Visiting Professor of Psychiatry, Duke University
1980 Fellow, American College of Neuropsychopharmacology (FACNP)
1981–1988 Part-time Acting Clinical Director, McLean Hospital
1983– Johns Hopkins University Scholar
1984 Upjohn Visiting Professor of Psychiatry, New York University, New York, NY
1984–1998 Fellow, American College of Psychiatrists (FACP)
1986– Founding Course Director: Advanced Clerkship on Psychotic Disorders, Harvard Medical School, Boston (HMS-501-M10B)
1986 Beverley Visiting Professor, Clarke Institute of Psychiatry, University of Toronto
1990 Ascher-Globus Visiting Professor of Psychiatry, Cornell-New York Hospital Medical Center
1990 Hernandez Visiting Professor of Psychiatry, Meharry Medical School, Nashville, TN
1990 Alexander Nies Visiting Scholar, University of Vermont College of Medicine
1992 Visiting Professor of Pharmacology & Psychiatry, University of Trondheim, Norway
1992 Visiting Professor of Psychiatry, Stanford University School of Medicine
1993 Residents' Association Annual Visiting Professor, University of Toronto
1993– Doctoral thesis supervisor in Physiological Psychology, Northeastern University
1994– Boots Visiting Professor of Pharmacology, Louisiana State University
1994 Dean’s External Reviewer, Department of Psychiatry, University of Toronto
1997 Sandoz Research Institute Visiting Professor, Columbia Medical Center, New York
1997 Residents' Choice Visiting Professor of Psychiatry, Yale Medical School
1997 Visiting Professor, Karl Menninger School of Psychiatry & Mental Health Sciences, Topeka, KS
1998 First Robert deVito Visiting Professor of Psychiatry, Loyola–Stritch Medical School, Chicago,
1999 Beverley Visiting Professor, Addiction and Mental Health Institute, University of Toronto
2001 Visiting Professor of Psychiatry, Stanford University
2003 Director, Psychopharmacology Training McLean Hospital
2003 Eli Lilly Visiting Professor, University of Iowa
2003 Visiting Professor of Psychiatry, Universities of Brescia, Parma, & Rome, Italy
2003 Distinguished Life Fellow of the American Psychiatric Association (DLFAPA)
2004 Visiting Professor of Psychiatry, Mayo Foundation, Rochester, MN
2004 Visiting Professor of Psychiatry, Dartmouth-Hitchcock Medical Center, Hanover, NH
2005 Weisel-Braceland Visiting Professor, Institute of Living, Hartford, CT, 2005
2006 Visiting Professor of Psychiatry, Pennsylvania State Medical Center, Hershey, PA, 2006
2007 Visiting Professor of Psychiatry, University of Helsinki
Selected Committee Responsibilities
1969 Consulting Member, Small Grant Study Section, National Institute of Mental Health
1970–1977 Committee on Psyhchiatry Residency Selection & Training, Massachusetts General Hospital, Boston
1972–1982 Thesis Advisor & Lecturer, Predoctoral Training Program, Department of Pharmacology, Harvard Medical School, Boston, MA
1974–2000 Examiner, American Board of Psychiatry and Neurology
1974–1977 Senior Staff Steering Committee; Committee on Promotions and Appointments, Psychiatry Dept., Massachusetts General Hospital, Boston
1975–1976 Member, Search Committee for the Associate Director for Research of Mass. General Hospital
1975–1976 Ethics Committee, Massachusetts Psychiatric Society
1975–1976 Member, Executive Committee on Research, Massachusetts General Hospital
1975–1976 Chairman, Subcommittee on Review of Research Proposals, Massachusetts General Hospital
1975–1985 Regional Representative, Johns Hopkins University School of Medicine, Admissions Committee
1976 Vice-President & Commissioner, Association for Research in Nervous and Mental Disease (ARNMD)
1976–1977 Task Force on ECT of the American Psychopathological Association
1976–1978 Co-director, Boston Collaborative Program on Biological Research in Schizophrenia
1976–1980 Chairman, Task Force on Tardive Dyskinesia of the American Psychiatric Association
1976– Committee on Research, McLean Hospital, Belmont, MA
1977– Associate Director, NIMH Psychobiology Training Program, Harvard Medical School, Boston
1977– Committees on Residency Selection and Education, McLean Hospital, Belmont, MA
1978– General Executive Committee, MeLean Hospital, Belmont, MA
1978–1981 Search Committee: Professor of Psychiatry, Childrens Hospital-Harvard Medical School
1978– Executive Subcommittee on Research, McLean Hospital, Belmont, MA
1978–1979 Committee of Professors, Harvard Medical School. Boston
1978–1985 Executive Committee, Department of Psychiatry, Harvard Medical School
1979–1980 Chairman, Task Force on Long-Term Planning for Research Administration, McLean Hospital
1979–1983 Member, Grant Review Committee on Preclinical Psychopharmacology, NIMH
1979–1989 Ad hoc committee on professorial appointments in psychiatry, Harvard Medical School
1980 Association of American Medical Colleges, Council on Graduate Eedical ducation
1980–1983 Chairman, NIMH Basic Psychopharmacology & Neuropsychology Grant Review Committee
1983–1984 Consulting member, Task Force on Biological Testing, American Psychiatric Association
1980–1985 American Psychiatric Association Commission on Psychiatric Therapies; Leader, Group on Antipsychotic Drug Treatment
1981 Member, American Psychiatric Association visiting committee to the People's Republic of China
1981–1982 Search Committee, Dorn Chair of Neuroscience/Neurology, Harvard Medical School
1981– Postgraduate Fellowship Review Committee, McLean Hospital
1981 Chairman, Annual Program for Scientific Advisors to the McLean Hospital
1982–1992 Executive Committee, Boston Society of Neurology and Psychiatry
1982– McLean Hospital Committee of Professors
1984–1985 Program Committee, American Society of Pharmacology & Experimental Therapeutics.
1985–1986 Member, 175th Anniversary Symposium and Program Committee, McLean Hospital
1985–1988 Founding Chairman, Institutional Animal Care and Use Committee, McLean Hospital
1985–1988 Member, Subcommittee of Professors Harvard Medical School, Boston
1985–1990 Member, Task Force on Therapeutics, McLean Hospital
1986–1987 President, Boston Society of Neurology and Psychiatry
1986–1992 Associate Director, Intro. Course: Psychopathology & Psychiatry, Harvard Medical School
1987 Member, Trustees' Committee on Research & Development, Massachusetts General Hospital
1987– Member, McLean Hospital Postgraduate Fellowship Committee
1987–1988 Member, Audiovisual Committee, McLean Hospital
1987–1990 Member, Committee on Research, Massachusetts General Hospital, Boston
1987–1988 Member, Committee of Professors of Psychiatry, Harvard Medical School
1988–1991 Member, Molecular Neuroscience Planning Committee, McLean Hospital
1988–1990 Member, Selection Committee, Dana Foundation Fellowship Program, Harvard Medical School
1988–2003 Member, Medical Research Advisory Board, The Boston Foundation
1988– Founding Director, Advanced Clerkship in Psychotic Disorders, Harvard Medical School
1989 Member, Advisory Board, VAMC Psychiatry Program, Brockton, MA
1989 Member, External Advisory Board: University of Pittsburgh Schizophrenia Center
1992– Member, Adolf Meyer Research Fellowship Development Committee, Johns Hopkins Hospital
1992–1997 Member, External Advisory Board, NIMH Clinical Research Center, University of Pennsylvania
1994 Dean’s invited external reviewer, Department of Psychiatry, University of Toronto
1994– Executive Committee on Patient Care Assessment, McLean Hospital
1994– Junior Faculty Mentor in Psychiatry, Harvard Medical School
1994– Member, Pharmacy & Therapeutics Committee, McLean Hospital
1995– Formulary Committee, McLean Hospital
1995– Member, Adverse Drug Reaction Team, McLean Hospital
1995– Consultant in psychopharmacology, US Pharmacopeia, Washington, DC
1995 Chairman, Trustees Task Force on Research, McLean Hospital
1996– Member, McLean–Massachusetts General Hospital Residency Training Committee
1998–1999 Member, Search Committee for Director of Psychiatry, Partners HealthCare Inc., Boston
1998–1999 Member, Search Committee for Director of Geriatric Psychiatry, Partners HealthCare Inc., Boston
1998–1999 Member, Search Committee for new scientists, Mailman Research Center, McLean Hospital
1988– Member, Advisory Board on Drug Development, Eli Lilly Research Center, Indianapolis
1998– Member, Advisory Board on treatment of bipolar disorder, Eli Lilly Corporation, Indianapolis
1998–2003 Co-Director, MGH-McLean Residency seminars program in biomedical psychiatry
1998 Chairman, International Symposium on Therapeutics and Suicide, Miami, FL
1999– Founding Scientific Advisor, Child and Adolescent Bipolar Disorder Foundation (CABF), Chicago
1999– Member, Psychiatry Research Committee, Partners HealthCare Corporation, Boston
2000– Founding Scientific Advisor, Understanding Manic Depression Foundation, New York
2001– Founding Scientific Advisor, Juvenile Bipolar Research Foundation, New York
2001–2003 Member, Task Force on Suicide, American Psychiatric Association
2001– Member, advisory council, Child and Adolescent Bipolar Disorder Foundation (CABF)
2003–2005 Member, Task Force on Antidepressants & Suicide, Amer. College of Neuropsychopharmacology
2003– Member, Committee on Evaluation of Clinical Training Programs, Harvard Medical School
2004 Founding Director, International Society for CNS Drug Trials & Methods ( ISCTM)
2005 Ad hoc committee on professorial appointment, Harvard Medical School
2007–2008 McLean Long-Range Planning Subcommittee on Psychotic Disorders
2007–2008 McLean Long-Range Planning Task Force
2010– Consulting member, Harvard Medical School and Partners HealthCare Center for Drug Policy
2011–14 Member, Task Force on Antecedents to Adult Bipolar Disorder, International Society for Bipolar Disorders.
2012–14 Member, Task Force on Antidepressant Treatment in Bipolar Disorder, International Society for Bipolar Disorders
2013–14 Member, search committee for Associate Professor of Clinical Psychiatric Research, McLean Hospital
2014– Member, Task Force on Lithium Treatment in Bipolar Disorder, International Society for Bipolar Disorders
Editorial Boards
1974–1992 Editorial Board, Neuropharmacology
1975–2010 Editorial Board, Archives of General Psychiatry
1975–1996 Consulting Editor, International Review of Neurobiology
1976– Editorial Board, Archives Internationales de Pharmacodynamie et de Therapie
1976–1978 Editorial Advisory Board, Harbor Area Somatic Therapy Newsletter
1977–1984 Editorial Board, Psychosomatic Medicine
1977– Editorial Review Panel, New England Journal of Medicine
1977– Editorial Review Panel, Psychopharmacology
1977– Editorial Review Panel, Biochemical Pharmacology
1977–2007 Editorial Advisory Board, Progress in Neuropsychopharmacology & Biological Psychiatry
1978– Editorial Board, Biological Therapies in Psychiatry, Tucson, AZ
1976–1980 Editorial Board, Weekly Psychiatry Update Series, Biomedia, Inc., Princeton, NJ
1980– Editorial Board, Directions in Psychiatry, Hatherleigh Press, New York, NY
1981–1988 Associate Editor, American Journal of Psychiatry
1982– Editorial Board, Journal of Clinical Psychopharmacology
1984–1993 Associate Editor, Journal of Clinical Psychiatry
1985–1992 Editorial Board, McLean Hospital Journal
1986–1992 Editorial Board: Neuropsychopharmacology
1987– Founding Editorial Board, Journal of the British Association for Psychopharmacology (London)
1988-1989 Editorial consultant, Comprehensive Textbook of Psychiatry, Baltimore:
Williams & Wilkins
1989– Founding Editorial Board Member, Journal of Psychopharmacology (London)
1989– Editorial Board, Progress in Neuropsychopharmacology and Biological Psychiatry
1989–1997 Editorial Advisory Board, Human Psychopharmacology, Clinical and Experimental
1990– Editorial Board, Advances in Neuropsychiatry and Psychopharmacology, Raven Press, New York
1992– Editorial Board, Current Approaches to the Psychoses, Elsevier-Excerpta Medica, Princeton, NJ
1992 Assoc. Editor, APA Treatment Manual: American Psychiatric Association, Washington, DC
1993– Editorial Board, CNS Drugs, Auckland, NZ
1994– Editorial Board, Schizophrenia Research
1994– Editorial Board, Neuropsychiatry: An International Update
1995– Editorial Board, American Journal of Therapeutics
1995– Editorial Advisory Board, Essential Psychopharmacology, Hatherleigh Press, New York
1996–2004 Editorial board, International Review of Neurobiology
1997– Editorial Board, McLean Hospital Psychiatric Update
1997– Founding editorial board member, Atlantic Psychopharmacology Quarterly
1998– Editorial Board, Bipolar Disorders Journal
2004– Editorial Board, Current Psychiatry Reviews
2006– Editorial Board, Clinical Schizophrenia and Related Psychoses
2010– Editorial Board, Brazilian Journal of Psychiatry (Jornal Brasilerio de Psychiatria)
2011– Editorial Board, World Journal of Pharmacology
2011– Editorial Board, Clinical Neuropsychiatry (Rome)
2012– Senior Advisory Board, International Journal of Bipolar Disorders
2012– Editorial Board, World Journal of Psychiatry
2014 Editorial Board, Clinical Psychopharmacology and Neuroscience
2015– Editorial Board, Düşünen Adam: Journal of Psychiatry and Neurological Sciences, Turkey
2016– Editorial Board, World Journal of Pharmacology
Memberships
1957– Theta Delta Chi Fraternity
1958– Phi Beta Kappa Honor Society
1959– Nu Sigma Nu Medical Society
1966–1969 Baltimore-Washington Neurological Society
1966–1969 Maryland Psychiatric Society
1966– American Psychiatric Association
1969– Staff Associates, Massachusetts General Hospital
1969–1973 Northern New England Psychiatric Society
1969–1975 American Association for the Advancement of Science
1970-1973 American Medical Association: Suffolk County Medical Society & Massachusetts Medical Society
1970– American Neurochemical Society
1970– Society for Neuroscience
1970– International Brain Research Organization
1971– Psychiatric Research Society
1971–1985 Boston Society for Psychiatry and Neurology (Member, Executive Committee, 1983-85)
1972– American Society of Pharmacology and Experimental Therapeutics
1973– Massachusetts Psychiatric Society
1973– Association for Research in Nervous and Mental Disease (Vice President, 1976)
1973– American Psychopathological Association
1974– American College of Neuropsychopharmacology
1975– Baystate PRSO, Inc.
1976– American Chemical Society, Division of Medicinal Chemistry
1976– International Society for Biochemical Pharmacology
1977– Brain Neurochemicals and Behavior Group of the Society for Neuroscience
1978–1980 Boston Neuroendocrinology Society
1980–1981 Finnish Psychiatric Society (Honorary Corresponding Member)
1981– Finnish Psychiatric Society (Corresponding Fellow)
1981– World Federation of Societies of Biological Psychiatry
1983– American Society for Biological Psychiatry
1985– Boston Society for Neurology and Psychiatry (Founding Member, Board of Directors)
1986– Associate, The Behavioral and Brain Sciences Associates, Princeton, NJ
19861987 President, Boston Society for Neurology and Psychiatry
1986–1990 Member, Newton South High School Parent-Teacher-Student Association, Newton, MA
1986- Life Member, Friends of McLean Hospital
1987–1988 Royal Society of Medicine, London (Affiliate Member)
1987– Neuropharmacology Division, American Society for Pharmacology and Experimental Therapeutics
1988– International Basal Ganglia Society
1988– International Brain Research Organization (IBRO)
1989– Bulfinch Society of Massachusetts General Hospital
1990– International College of Neuropsychopharmacology (CINP)
1992– Founding Member, American Society of Clinical Psychopharmacology
1994– Founder, International Consortium for Bipolar Disorder Research
1997– Professional Associate, National Alliance for the Mentally Ill (NAMI)
1999– Member, New England Council for Child and Adolescent Psychiatry
1999– Founding member, International Society for Bipolar Disorders
2000– Founding member, Federation of European Neuroscience Societies
2001– Member, Boston Interuniversity Group for the History of Science & Philosophy
2001– Founding Fellow, International Society for Affective Disorders
2004– Founding member, National Foundation for Mental Health
2004– Founding director, International Society for CNS Clinical Trials and Methods (ICTM)
2005– Member, American Diabetes Association
Awards,Honors
Phi Beta Kappa, Williams College, 1958
Highest honors in Chemistry, A.B. Magna cum Laude, Williams College, 1959
Robson Chemistry Prize, Williams College, 1959
Theta Delta Chi Scholar, 1959-1961
Summer Fellow in Pathology, North Adams Regional Hospital, North Adams, MA, 1960
Fellow, Massachusetts Institute of Technology Neurosciences Research Program Intensive Study Program, 1969
Recipient, National Institute of Mental Health Research Career Development Award, Type II (1-KO2-MH-47370), 1970-1975
Northern New England Psychiatric Association Research Prize: First Honorable Mention, 1971
Diplomate, American Board of Psychiatry and Neurology, 1972 (#11769)
Recipient, National Institute of Mental Health Research Scientist Award (1-KO5MH-47370), 1975-2000
Daniel Efron Research Prize of the American College of Neuropsychopharmacology (ACNP), 1976
Fellow, American Psychiatric Association (FAPA), 1977-
Honorary Master's Degree, Harvard University, 1978
Fellow, American College of Neuropsychopharmacology (FACNP), 1980-
Blacklin Lecturer, University of Tennessee, Memphis, 1981
Goldwyn Lecturer, University of Massachusetts Medical School, Worcester, 1983
Fellow of the American College of Neuropsychopharmacology (FACNP), 1976
Society of Scholars, Johns Hopkins University, 1983-
Fellow, American College of Psychiatrists (FACP), 1984
Wyeth-Ayerst Research Prize Co-investigator, VIII World Congress of Psychiatry, Athens, 1989
Fellow, International College of Neuropsychopharmacology (FCINP), 1990–
Alexander Nies Visiting Scholar, University of Vermont College of Medicine, 1990
Invited Plenary Lecturer, Third International Congress on Schizophrenia Research, Tucson, AZ, 1991
Invited Plenary Lecturerer, Norwegian Society of Pharmacology, Beito, Norway, January, 1992.
Member, Gilman Society, Johns Hopkins University, 1992-
Boots Distinguished Neuroscientist Award, Louisiana State University, 1994
Honorary Doctor of Science, North Adams State College, 1995
Third Cleghorn Memorial Lecturer, McMaster Univrsity, Hamilton, Ontario, May, 1995
Janssen Visiting Professor of Psychiatry, University of Miami, January, 1997
Invited Plenary Lecturer: American Society for Clinical Psychopharmacology, Barbados,
February, 1997
First Outstanding Postgradute Educator Award, New England Educational Institute, Pittsfield,
MA, June, 1998
Nominee, Harvard Medical School Barger Award for Mentoring, 1998, 2001, 2002
Member, National Council for Johns Hopkins Medicine, 1999–
Member, William Henry Welch Society of Johns Hopkins University, 1999–
Nominee: Research Prize of the American Psychiatric Association, 2000
Plenary Speaker, 100th Anniversary, Ohio Psychiatric Association, Columbus, April, 2000
Nominee: Anna-Monika Foundation Prize for Research on Major Affective Disorders, 2001
Life Fellow, American Psychiatric Association (LFAPA), 2001–
Philip Isenberg Psychiatry Teaching Award, Massachusetts General & McLean Hospitals, 2001
American Society for Information Science & Techology (ISI) Highly Cited Researchers
recognition, 2002
Distinguished Life Fellow of the American Psychiatric Association (DLFAPA), 2003
Falcone-NARSAD Prize for Research on Bipolar Disorder, October, 2003
Plentary International Lecturer (Lectura Magistralis), Italian Society for Psychopathology
(SOPSI), Rome, Italy, February, 2004
Research Prize, American Foundation for Suicide Prevention, New York, NY, May, 2004
Invited Lecturer, Japanese Lithium Research Society, Hiroshima, Japan, April, 2004
ISI Most Cited in pharmacology and psychiatry, 2004:
http://hcr3.isiknowledge.com/author.cgi?&link1=Browse&link2=Results&id=1696
Outstanding Psychiatrist–Advancing the Profession Award, Massachusetts Psychiatric Society,
May, 2005
Harvard Medical School Excellence in Mentoring Award nominee, February, 2006
Plenary International Lecturer (Lectura Magistralis), Italian Society for Psychopathology
(SOPSI), Rome, Italy, February, 2006
Visiting Professor of Psychiatry, Milton Hershey/Pennsylvania State University Medical
Center, Hershey, PA, November, 2006
Inaugural Member, Outstanding Health Professionals Worldwide, January, 2007
America’s Top Doctors of 2006 Award, American Registry, January 2007
Visiting Professor Québec Psychiatric Association, Montréal, February 2007
Visiting Professor of Psychiatry, University of Helsinki, Finland, March, 2007
Plenary Keynote Lecturer, Finnish Psychiatric Association, March, 2007
Research Medal, Finnish Psychiatric Association, March, 2007
Keynote speaker, American Association of CNS Pharmacists, Boulder, CO, April 2007
American Registry: America’s Top Doctors for 2007
Research Prize: International Symposium on Biological Psychiatry, Thessaloniki, Greece,
December, 2007
McCurdle Lectureship nominee, Cambridge University, Cambridge, England, 2008
Harvard Medical School Excellence in Mentoring Award runner-up, February, 2006
Chemical Reviews most cited papers of 2007 (Zhang A, Neumeyer JL, Baldessarini RJ. Recent
progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders. Chem Rev 2007; 107; 274–302)
Harvard Medical School Excellence in Mentoring Award runner-up, February, 2010
Finalist, McLean Hospital Cataldo Award for Mentoring, March 2010
Marc H. Hollender Visiting Professorship of Psychiatry, Vanderbilt University, Nashville, TN,
April 2010
Anne Cataldo Mentoring Award, McLean Hospital, September, 2010.
William Silen Lifetime Mentoring Award, Harvard Medical School, June 2012
James Hegarty Memorial Lecturer, Chambersburg Hospital, Chambersburg, PA, June 2013
Guest editor, special issue of Canadian Journal of Psychiatry, 2014
Sterling Visiting Professor of Pharmacology, Sackler School of Graduate Biomedical Sciences,
Tufts University, Boston, 2014
Consultantships,EditorshipsandMiscellaneousPositions
1970-77 Consultant for Psychiatric Research, Veterans Administration Hospital, Bedford, MA
1970-77 Committee on Research, Massachusetts General Hospital, Boston
1972-73 Consultant for the Development of Neuropsychopharmacological Research Programs, Departments of Pharmacology and Psychiatry, McMaster University, Hamilton, Ontario
1972-77 Consultant in Psychopharmacology and Residency Education Program, McLean Hospital
1973-00 Consultant in Psychiatry & Psychopharmacology, Westwood Lodge Hospital, Westwood, MA
1973-77 Consultant, Inpatient Service & Pharmacy Committee, Lindemann Mental Health Center, Boston
1974-90 Consultant in CNS Pharmacology, Bio-Research Laboratories, SpA, Milan, Italy
1974-77 Member of Courtesy Staff, McLean Hospital, Belmont, MA
1974-77 Consultant on design of Mailman Neuroscience Research Center, McLean Hospital
1975-76 Consultant, Arnar-Stone Laboratories, Mt. Prospect, IL
1976-77 Consultant to the American Society of Hospital Pharmacists for the US FDA
1976-77 Consultant, Physicians Continuing Medical Education Radio Network, New York
1978-79 Course Co-Director: Introductory Psychiatry, Harvard Medical School, Boston
1978-79 Consultant to the Federal Circuit Court of Boston (Amicus Curiae Brief: Chayet & Sonnenreich)
1978- Lecturer, Department of Psychology, Harvard College
1979-84 Consultant, Training Program in Behavioral Neurobiology, Northwestern University, Evanston, IL
1979 Consultant in Psychiatry & Psychopharmacology, Chestnut Lodge Hospital, Rockville, MD
1980-90 Consultant in Neuropharmacology and Psychopharmacology to Sandoz Ltd., Basel, Switzerland
1980-85 Course Director, Biomedical Aspects of Psychiatry, McLean Hospital
1980-86 Consultant to Program in Biology and Industrial Relations, University of Massachusetts
1982-85 Lecturer and Coinvestigator, Graduate Training in Pharmacology, Harvard Medical School
1982-93 Member, Board of Directors, Research Biochemicals, Inc., Natick, MA
1982- Member, Review Committee for Psychiatry Dept., University of Texas Medical Center, Houston, TX,
1982 Consultant to the Vice President for Medical Affairs, Duke University
1982 Consultant to the Dean, Vanderbilt University School of Medicine
1982 Consultant to the Dean, University of Pennsylvania School of Medicine
1983 Reporting faculty member, Dean's Committee on a proposed reorganization of McLean Hospital
1983 Consultant to Grants Review Program Committee, National Institute of Mental Health, Bethesda, MD
1983 Consultant to the Board of Scientific Counsellors, National Institute of Mental Health
1984 Consultant, Carrier Clinic, Princeton, NJ
1984 Consultant in Neuropharmacology, Squibb Pharmaceuticals Corp., Princeton, NJ
1984 Consultant to Friends and Families of Schizophrenia, Honolulu, Hawaii
1984 Consulting Member, NIH Consensus Conference on Treatment of Mood Disorders, Bethesda, MD
1984 Consultant to the Department of Mental Health, Commonwealth of Massachusetts.
1984-86 Consultant on CNS pharmacology, Upjohn Pharmaceuticals Co., Kalamazoo, MI
1984 Consultant to the Dean, University of North Carolina School of Medicine, Chapel Hill
1985- Member, American Red Cross of Massachusetts Bay
1985 Consultant to the Dean, Yale School of Medicine
1985-90 Consultant in CNS Pharmacology, Sandoz Laboratories, Basel, Switzerland
1985- Consultant in CNS Pharmacology, Wander Research Institute, Berne, Switzerland
1985- Consultant, Division of Drugs and Technology, American Medical Association, Chicago, IL
1986-88 Consultant to the Psychiatric Times and Postgraduate Education Corporation, Santa Ana, CA
1986-90 Associate of the Smithsonian Institution, Washington DC
1986 Director: Postgraduate Course in Clinical Psychopharmacology, Psychiatric Institute, Washington, DC.
1986-88 Consultant: American Psychiatric Association Task Force on Treatment of Psychiatric Disorders
1986-90 Founding Course Co-Director: Introduction to Clinical Psychiatry (No. 700), Harvard Medical School
1986-90 Consultant: Pain Program Project, Massachusetts General Hospital, Boston MA
1987-90 Member, Massachusetts Society for Prevention of Cruelty to Animals (MSPCA)
1987- Consultant to the Massachusetts Mental Health Center Commonwealth Research Center
1987-88 Consultant in CNS Pharmacology, Bristol-Myers Research Division, Wallingford, CT
1987 Consultant to the Department of Mental Health, State of Colorado
1987-90 Consultant in Psychopharmacology, New York Department of Mental Health, Albany, NY
1987-90 Consultant in Neuropharmacology, Stuart-ICI-Americas Pharmaceuticals Inc., Wilmington, DL
1988 Consultant to Jonathan Livingston Foundation Fellowship Program, Boston
1988 Thesis Advisor: Department of Epidemiology, Harvard School of Public Health, Boston
1988- Member, Editorial Panel, Journal of Neuropsychiatry and Clinical Neurosciences
1988-95 Thesis advisor, School of Pharmacy, Northeastern University, Boston
1988-89 Consultant, Marion Laboratories, Kansas City, MO
1988-90 Consultant in Neuropharmacology, CNS Research Corporation, Cambridge, MA
1989- Member, External Advisory Board, VAMC Schizophrenia Center, Yale University
1989- Member, Neuropharmacology Division, American Soc. Pharmacology & Exptl Therapeutics
1989- Consultant in Psychopharmacology, U.S. Veterans Administration
1990- Consultant to Marion-Merrell-Dow Laboratories, Kansas City, MO
1991- Consulting Member, Canadian Association for Psychiatric Research Research Prize Committee
1992 Consultant to Task Force on Psychiatric Treatment, American Psychiatric Association, Washington
1993–94 Consultant in psychopharmacology, Pfizer Central Research, Groton, CT
1993–94 Member, Scientific Advisory Board, Research Biochemicals Incorporated (RBI), Natick, MA
1993-94 Consultant, Westat Corporation, Rockville, MD
1993-98 Consultant, Neuromedica, Inc., Cambridge, MA
1993-94 Scientific Advisor, Neuromedica, Inc., Cambridge, MA
1994- Selectee, American Men and Women of Science
1995-97 Member, Committee on Carreer Development in Psychiatry, Harvard Medical School
1995 Consultant, Chinman-Hoenig Medical-Psychiatric Associates, Wayland, MA
1995 Consultant, Medical Research International AG, Burlington, MA
1995 Consultant on psychotic disorders, Menninger Clinic, Topeka, KS
1995 Consultant on psychotic disorders, McMaster University College of Medicine, Hamilton, Ontario
1996– Member, Massachusetts Department of Mental Health Practice Guidelines Review Panel
1996 Consultant to the Board of Directors, The Medical Foundation (TMF) of Boston
1997 Consultant to the US VA Psychiatry Department on treatment of bipolar disorders
1997 Consultant in Psychopharmacology to Janssen Foundation
1997– Consultant in Psychopharmacology to Eli Lilly Laboratories
1997– Consultant in pharmacology and CNS drug development, Copley Pharmaceuticals
1997– Consultant in neuropharmacology to Hoechst Pharmaceuticals
1998– Consultant in psychopharmacology, Eli Lilly Company
1998-03 Consultant, Neuromedica, Inc., Conshohocken, PA
1998– Consultant in Neuropharmacology, Robert Wood Johnson Research Institute
1999– Founding International Advisor, Canadian National Consortium for Bipolar Disorders Research
2001– Consultant, Glaxo-SmithKline Corporation
2001– Consultant on antipsychotic drug development, Solvay Corporation
2001– Director, International Collaborative Study: olanzapine treatment for mania, Eli Lilly Research
2001– Consultant, IFI Pharmaceuticals SpA, Rome, Italy
2002–03 Consultant, Alkermes Corporation, Cambridge, MA
2002– Consultant, Janssen Pharmaceuticals Inc., Titusville, NJ
2002– Consultant, Auritec Laboratories, Los Angeles, CA
2002– Consultant, Johnson & Johnson Corporation, NJ
2002– Consultant, Unihart Biotech Pharma NV, Amsterdam, Netherlands
2003- Consultant, JDS Pharmaceuticals, New York, NY
2004 Consultant, special task force on olanzapine risks vs. benefits, Eli Lilly & Co.
2005 Consultant, special task force on suicidal risks of antidepresssants, Eli Lilly & Co.
2005– Consultant, Novartis Pharmaceutical Corporation, East Hanover, NJ
2006– Consultant, BioTherapeutix LLC, Waltham, MA
2006– Consultant, Merck Laboratories, Rahway, NJ
2007– Director, Newton-Wellesley-Weston Program for Community Living, Newton, MA
2010 Consultant, Alkermes Corporation, Waltham, MA
2010 Consultant, Johnson & Johnson Corporation, New Brunswick, NJ
2012– Consultant, College of Pharmacy, University of Colorado, Denver, CO
Ross J. Baldessarini
May 19, 2016